CIK 0001533998 · Non-accelerated filer<br>Smaller reporting company
DarioHealth Corp.
Sign in to watch- Ticker
- DRIO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452973162
- Phone
- 972-4-770-6377
- Business address
- 322 W 57TH ST. #33B, NEW YORK, NY, 10019
- Former names
- LabStyle Innovations Corp.
- 4 Open-market buy Chief Commercial Officer bought 15,000 shares at an average $0.82 ($12,292)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $0.88 ($4,400)
- 4 Open-market buy Chief Commercial Officer bought 15,000 shares at an average $0.94 ($14,147)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $0.94 ($9,400)
- 4 Open-market buy Chief Commercial Officer bought 10,000 shares at an average $0.93 ($9,283)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $0.90 ($8,980)
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Executive or director change · Shareholder vote results
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
Page 7 of 46 · 905 filings